Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs. The company’s current medical opportunities … Continue reading →

Sernova is a clinical-stage company developing products that provide a natural and immune-protected environment for delivering therapeutic cells to patients. The company is developing two novel closely integrated proprietary platform technologies: Cell Pouch System™ and Sertolin™. SVA’s products may benefit … Continue reading →

Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs using drug delivery technologies. The company has three products, all of which are approved by the FDA: Lipofen® for the treatment of high cholesterol; ConZip®/Durela® for … Continue reading →

Bavarian Nordic is a vaccine-focused biotech company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases. In oncology, the company’s lead program is PROSTVAC®, a therapeutic vaccine candidate for advanced prostate cancer and the subject of … Continue reading →

MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests to support cancer treatment. The company utilizes its proprietary, patented DNA methylation platform and biomarkers to offer tests that aid in the improvement of cancer diagnostics, prognosis … Continue reading →

Fluoropharma is engaged in the discovery, development and commercialization of molecular imaging pharmaceuticals with primary applications in the area of cardiology. The company’s BFPET is in phase I trial used for the detection of ischemic and infarcted tissue within the … Continue reading →

Bionomics is a drug discovery and development company focused on new treatments for cancer and serious disorders of the central nervous system (CNS). The company utilizes its technology platforms with the aim of identifying and developing therapies to treat cancer … Continue reading →

Navidea Biopharmaceuticals is a biopharm company focused on the development and commercialization of precision diagnostic agents. NAVB’s radiopharmaceutical development programs include Lymphoseek, a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent; and RIGScan, a tumor antigen-specific targeting agent. … Continue reading →